50 likes | 72 Views
The global automated endoscope reprocessing device market exhibited a value of USD 433.2 million in 2017, and is expected to reach USD 683.5 million by 2025, growing at a CAGR of 5.9% during 2018–2025.The key factors boosting the market growth are paradigm shift towards automated endoscope reprocessing from manual cleaning procedures, rising concerns pertaining to infection free endoscopy and rising technological advancement and spending on healthcare facilities.
E N D
Surging demand from healthcare industries, such as hospital facilities, ambulatory surgical centres, specialty clinics worldwide has led to burgeoning market growth of automated endoscope reprocessing device market Posted by Sarah Nash October 22, 2018 in Healthcare The global automated endoscope reprocessing device market exhibited a value of USD 433.2 million in 2017, and is expected to reach USD 683.5 million by 2025, growing at a CAGR of 5.9% during 2018–2025.The key factors boosting the market growth are paradigm shift towards automated endoscope reprocessing from manual cleaning procedures, rising concerns pertaining to infection free endoscopy and rising technological advancement and spending on healthcare facilities. Double basin endoscope reprocessing device is expected to exhibit the highest CAGR during the forecast period owing to surging adoption
rate of double basin automated endoscope reprocessors in hospitals, especially in infection prevention and control department and rising awareness regarding the use of double basin endoscope reprocessing. Download Sample Brochure : https://www.gmiresearch.com/sample- research-report.php?rid=125 Some of the other factors affecting the market growth are rising concerns pertaining to infection free endoscopy, expansion via partnerships & collaborations and stringent rules & regulation in healthcare industry. Moreover, apart from this, the technological advancements and improving reimbursement policy are further likely to drive the growth in the automated endoscope reprocessing device market, globally. Hospital segment hold the largest market share in the 2017 and is predicted to grow at an estimated CAGR of 6.0% during the forecast period owing to rising adoption and penetration of automated endoscope reprocessing devices in Hospital. Also, significant healthcare spending and increasing government & private investments for healthcare facilities infrastructure are expected to lay down the best path for the market to grow “Strategic collaboration among manufacturers, healthcare providers, accrediting organizations, professional societies, and government agencies may help to design, approve and distribute automated endoscope reprocessing devices throughout the world, hence, such collaboration will benefit all stakeholders in the coming years”—-GMI Research
Based on geography, North America held the largest share in the market in 2017 on account of well-established healthcare infrastructure and adequate reimbursement policy increase demand in end-use verticals, majorly in hospital and ambulatory surgical centres coupled with stringent government rule and regulation. Asia-Pacific is the fastest growing region in the global automated endoscope reprocessing device market and is projected to grow at CAGR of 5.3% during 2018-2025. Increasing government and private funding for the healthcare infrastructure, rising medical tourism and increasing adoption of automated endoscope reprocessing device for the reprocessing of endoscopes are key factors which are supporting the growth of the market in the region. Key takeaways: • Double basin endoscope reprocessing device is expected to exhibit the highest CAGR during the forecast period • Hospital segment hold the largest market share in the 2017 and is predicted to grow at an estimated CAGR of 6.0% during the forecast period • North America held the largest share in the market in 2017 • Asia-Pacific is the fastest growing region in the global automated endoscope reprocessing device market and is projected to grow at CAGR of 5.3% during 2018-2025 Some of the key players operating in the global automated endoscope reprocessing device market, include STERIS Plc., Olympus Corporation, Getinge AB, Steelco S.p.A., Cantel Medical Corp., Laboratory Anios, Hoya Corporation, Metull Zug AG, Advanced Sterilization Products Services Inc. (Johnson & Johnson) among others.
The global automated endoscope reprocessing device market has been segmented on the basis of device type, modality type, end user and key geographies. Based on the device type, market is segmented into single basin automated endoscope reprocessing device and double basin automated endoscope reprocessing device. Based on Modality type, the market comprises of standalone and bench top. Based on end use, the market has been segmented into hospitals, ambulatory surgical centres and clinics. The research report “global automated endoscope reprocessing device market” provides in-depth analysis of automated endoscope reprocessing device across the globe, based on device type, modality, end user and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report also provides market size and forecast for automated endoscope reprocessing device market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market. For Sample Pages & Detailed Report Description Visit : https://www.gmiresearch.com/report/global-automated-endoscopic- reprocessing-market-2018-2025-share-trends-type-forecasts-insight- healthcare.html About US GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through
independent fact-based insight, ensuring their business achieve success by beating the competition. Contact – Sarah Nash Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate, Dublin D18 Y3X2, Ireland U.S Office +1 860 881 2270 Europe Office +353 1 442 8820 Email: sales@gmiresearch.com